Plasma brain natriuretic peptide after isolated on-pump coronary artery bypass grafting: Prediction of postoperative adverse outcomes

Heart Surgery Forum

Volumn 11, Issue 2, 2008, Pages 77-82

  Turk, Tamer ^a   Ata, Yusuf ^a   Ay, Derih ^a   Ozkan, Hakan ^b   Vural, Hakan ^a   Yavuz, Senol ^a   Ozyazicioglu, Ahmet ^a  

^a BURSA YUKSEK IHTISAS TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MEDICAL PARK HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; HEPARIN; NORADRENALIN;

ADULT; AGED; AORTA BALLOON; AORTA CLAMPING; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; ELECTIVE SURGERY; FEMALE; FLUORESCENCE ANALYSIS; FORWARD HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROC CURVE; BLOOD; CLINICAL TRIAL; INCIDENCE; METHODOLOGY; MIDDLE AGED; OFF PUMP CORONARY SURGERY; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICS; TREATMENT OUTCOME; TURKEY (REPUBLIC);

ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TURKEY;

EID: 42149175955     PISSN: 10983511     EISSN: None     Source Type: Journal    
DOI: 10.1532/HSF98.20071185     Document Type: Article

References (30)

1. Bettencourt P, Ferreira S, Azevedo A, Ferreira A. 2002. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure. Am J Med 113:215-9.
2. Cheng V, Kazanagra R, Garcia A, et al. 2001. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37:386-91.
3. Dao Q, Krishnaswamy P, Kazanegra R, et al. 2001. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37:379-85.
4. Dupuis JY, Wang F, Nathan H, Lam M, Grimes S, Bourke M. 2001. The cardiac anesthesia risk evaluation score: a clinically useful predictor of mortality and morbidity after cardiac surgery. Anesthesiology 94:194-204.
5. Francis GS, Benedict C, Johnstone DE, et al. 1990. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82:1724-9.
6. Gottlieb SS, Kukin ML, Ahern D, Packer M. 1989. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13:1534-9.
7. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. 1992. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score. JAMA 267:2344-8.
8. Hutfless R, Kazanegra R, Madani M, et al. 2004. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43:1873-9.
9. Krishnaswamy P, Lubien E, Clopton P, et al. 2001. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 111:274-9.
10. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. 1998. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135:825-32.
11. Maisel A. 2001. B-type natriuretic peptide levels: diagnostic and therapeutic potential. Cardiovasc Toxicol 1:159-64.
12. Maisel AS, Krishnaswamy P, Nowak RM, et al, for the Breathing Not Properly Multinational Study Investigators. 2002. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161-7.
13. Martinez-Alario J, Tuesta ID, Plasencia E, Santana M, Mora ML. 1999. Mortality prediction in cardiac surgery patients: comparative performance of Parsonnet and general severity systems. Circulation 99:2378-82.
14. McCullough PA, Nowak RM, McCord J, et al. 2002. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106:416-22.
15. Morita E, Yasue H, Yoshimura M, et al. 1993. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88:82-91.
16. Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H. 1997. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn Circ J 61:657-64.
17. Omland T, Persson A, Ng L, et al. 2002. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106:2913-8.
18. Parsonnet V, Dean D, Bernstein AD. 1989. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79:I3-12.
19. Pons JM, Espinas JA, Borras JM, Moreno V, Martin I, Granados A. 1998. Cardiac surgical mortality: comparison among different additive risk-scoring models in a multicenter sample. Arch Surg 133:1053-7.
20. Provenchere S, Berroeta C, Reynaud C, et al. 2006. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 34:995-1000.
21. Richards AM, Nicholls MG, Espiner EA, et al. 2003. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107:2786-92.
22. Saribulbul O, Alat I, Coskun S, et al. 2003. The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting. Tex Heart Inst J 30:298-304.
23. Shirasawa B, Hamano K, Kawamura T, et al. 2000. Does the serum brain natriuretic peptide (BNP) level after open heart surgery reflect myocardial protection? [in Japanese]. Kyobu Geka 53:123-6.
24. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. 2000. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355:1126-30.
25. Tu JV, Jaglal SB, Naylor CD. 1995. Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Circulation 91:677-84.
26. Tuman KJ, McCarthy RJ, March RJ, Najafi H, Ivankovich AD. 1992. Morbidity and duration of ICU stay after cardiac surgery: a model for preoperative risk assessment. Chest 102:36-44.
27. Wazni OM, Martin DO, Marrouche NF, et al. 2004. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 110:124-7.
28. Weightman WM, Gibbs NM, Sheminant MR, Thackray NM, Newman MA. 1997. Risk prediction in coronary artery surgery: a comparison of four risk scores. Med J Aust 166:408-11.
29. Wendelboe Nielsen O, Kirk V, Bay M, Boesgaard S, Nielsen H. 2004. Value of N-terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital Heart Failure study (CHHF). Eur J Heart Fail 6:275-9.
30. Yasue H, Yoshimura M, Sumida H, et al. 1994. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90:195-203.